A Case of Recalcitrant Psoriasis Improved with Tacrolimus (FK 506).
- Author:
Bong Gyun HAN
1
;
You Chan KIM
;
Hyang Joon PARK
;
Yong Woo CINN
Author Information
1. Department of Dermatology, College of Medicine, Dankook University Cheonan, Korea. kyccc@anseo.dankook.ac.kr
- Publication Type:Case Report
- Keywords:
Tacrolimus(FK 506);
Recalcitrant psoriasis
- MeSH:
Acitretin;
Cyclosporine;
Dermatitis, Atopic;
Female;
Humans;
Methotrexate;
Middle Aged;
Psoriasis*;
Steroids;
Tacrolimus*
- From:Korean Journal of Dermatology
2001;39(11):1313-1315
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Tacrolimus(FK 506) is a powerful immunosuppressant. Recently, topical and systemic tacrolimus was known to have therapeutic effects in various dermatologic diseases such as atopic dermatitis, psoriasis, pyodema gangrenosum, and Beh et's disease. A 48-year-old woman presented with psoriasis of 40 years duration, which was recalcitrant to any therapies including topical steroids and calcipotriol, UVB, PUVA, acitretin, cyclosporine, and methotrexate. Therefore, systemic tacrolimus treatment, at a dose of 2 to 6 mg per day, was initiated, and complete resolution of the lesions was observed after 2 months. We report a case of recalcitrant psoriasis improved with tacrolimus.
